METASTATIC SOLID TUMORS
Clinical trials for METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug combo tested for safety in advanced tumors
Disease control CompletedThis early-phase study tested a new drug called M6223, which targets the immune system to fight cancer. It was given alone or with another drug (bintrafusp alfa) to 58 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated May 26, 2026 05:31 UTC
-
Cancer drug safety checked in long-term study
Disease control CompletedThis study checked the long-term safety of the drug sacituzumab govitecan in 25 people with metastatic solid tumors (cancer that has spread) who were already benefiting from the treatment. Researchers tracked side effects and lab test changes. The goal was to understand how safe …
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE4 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 26, 2026 05:23 UTC
-
Immune cocktail shows promise in early trial for stubborn cancers
Disease control CompletedThis early-phase study tested a three-drug combination (IL-15, nivolumab, and ipilimumab) in 31 adults with cancers that no longer respond to standard treatments. The goal was to find the safest dose and see if the drugs could help the immune system attack tumors. Participants re…
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Immunotherapy cocktail shows promise in Hard-to-Treat cancers
Disease control CompletedThis study tested a new immunotherapy drug, ezabenlimab (BI 754091), combined with other cancer medicines in 211 adults with advanced solid tumors that had spread. The goal was to see if the combination could shrink or eliminate tumors. Participants received treatment as long as …
Matched conditions: METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Massive tumor study reveals rare genetic markers
Knowledge-focused CompletedThis study examined tumor samples from 3,820 people with advanced solid cancers to find how often NTRK gene fusions appear. Researchers used genetic tests to identify these rare changes. The goal was to understand the incidence, not to test a new treatment. Participants had alrea…
Matched conditions: METASTATIC SOLID TUMORS
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 26, 2026 05:34 UTC
-
New study reveals clues to survival after ER visits for advanced cancer
Knowledge-focused CompletedThis study looked at 1,250 adults with advanced cancer who visited the emergency room. Researchers checked medical records to find factors linked to survival in the next 90 days. The goal is to help doctors identify patients who need extra support or palliative care sooner.
Matched conditions: METASTATIC SOLID TUMORS
Sponsor: Ankara Etlik City Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 05:32 UTC